Global Autosomal Dominant Polycystic Kidney Disease Epidemiology Forecast Report to 2032 - ResearchAndMarkets.com
Retrieved on:
Friday, October 7, 2022
Genetics, Pharmaceutical, Health, Arachnoid, Epidemiology, Cyst, Hypertension, Colin L. Masters, Doctor of Philosophy, ERM, PKD2, Growth, Population, Diagnosis, Mitral valve prolapse, Kidney failure, Patient, Urinary tract infection, Degenerative disease, Renal cysts and diabetes syndrome, Kidney, Diverticular disease, Polycystic kidney disease, Hernia, Stabat Mater, Hematuria, Adult, Liver, United Kingdom, Fibrosis, PKD1, Master's degree, Intracranial aneurysm, Autosome, Left ventricular hypertrophy, Chronic kidney disease, Pancreas, Autosomal dominant polycystic kidney disease, PKD, Vaccine, Pharmaceutical industry, Lithium, Medical device, Health insurance, Management
The "Autosomal Dominant Polycystic Kidney Disease - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Autosomal Dominant Polycystic Kidney Disease - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.
- This report delivers an in-depth understanding of Autosomal Dominant Polycystic Kidney Disease, historical and forecasted epidemiology as well as Autosomal Dominant Polycystic Kidney Disease trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
- The diagnosed prevalent cases of Autosomal Dominant Polycystic Kidney Disease are likely to change by 2032 in the forecast period 2022-2032.
- The report provides the segmentation of the disease epidemiology for the 7MM, a total number of total Diagnosed Prevalent Cases of Autosomal Dominant Polycystic Kidney Disease, Age-specific cases of Autosomal Dominant Polycystic Kidney Disease, and Mutation-specific cases of Autosomal Dominant Polycystic Kidney Disease.